Sunshine Biopharma Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects

Sunshine Biopharma Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $1.40 on 05/11/23, while the lowest value for the same period was recorded at $0.04 on 03/04/24.

52-week price history of SBFM Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Sunshine Biopharma Inc’s current trading price is -92.06% away from its 52-week high, while its distance from the 52-week low is 153.30%. The stock’s price range during this period has spanned from $0.04 to $1.40. In the Healthcare sector, the Sunshine Biopharma Inc’s shares surpassed a trading volume of approximately 235.65 million for the day, which was noticeably higher compared to the average daily volume of 9.15.99 million over the past three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Market Capitalization and Financial Performance: An In-Depth Look

Sunshine Biopharma Inc (SBFM) has experienced a quarterly decline of -61.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 11.06M and boasts a workforce of 44 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1921, with a change in price of -0.1722. Similarly, Sunshine Biopharma Inc recorded 12,307,991 in trading volume during the last 100 days, posting a change of -59.36%.

Examining SBFM’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for SBFM stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.

SBFM Stock Stochastic Average

Today’s raw stochastic average for Sunshine Biopharma Inc over the last 50 days is 30.62%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 75.05%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 36.24% and 22.13%, respectively.

SBFM Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -59.04%.However, over the last six months, we can see a stronger performance of -65.25%. Over the last 30 days, the price of SBFM has fallen by 100.72%. And in the last five days, it has surged by 88.47%.

On Key

Related Posts